These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30519475)

  • 1. A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo.
    Donald S; Elliott M; Gray B; Hornby F; Lewandowska A; Marlin S; Favre-Guilmard C; Périer C; Cornet S; Kalinichev M; Krupp J; Fonfria E
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00446. PubMed ID: 30519475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.
    Hackett G; Moore K; Burgin D; Hornby F; Gray B; Elliott M; Mir I; Beard M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29751611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency.
    Burgin D; Périer C; Hackett G; Elliott M; Kwan D; Hornby F; Mir I; Maignel J; Liu SM; Beard M
    Toxins (Basel); 2021 Nov; 13(12):. PubMed ID: 34941672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal and specific quantitative detection of botulinum neurotoxin genes.
    Hill BJ; Skerry JC; Smith TJ; Arnon SS; Douek DC
    BMC Microbiol; 2010 Oct; 10():267. PubMed ID: 20961439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems.
    Elliott M; Maignel J; Liu SM; Favre-Guilmard C; Mir I; Farrow P; Hornby F; Marlin S; Palan S; Beard M; Krupp J
    PLoS One; 2017; 12(10):e0185628. PubMed ID: 28982136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.
    Broide RS; Rubino J; Nicholson GS; Ardila MC; Brown MS; Aoki KR; Francis J
    Toxicon; 2013 Sep; 71():18-24. PubMed ID: 23707612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S; Tepp WH; Bradshaw M; Kalb SR; Dykes JK; Lin G; Nawrocki EM; Pier CL; Barr JR; Maslanka SE; Johnson EA
    mSphere; 2016; 1(1):. PubMed ID: 27303710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum neurotoxin X lacks potency in mice and in human neurons.
    Gregg BM; Matsumura T; Wentz TG; Tepp WH; Bradshaw M; Stenmark P; Johnson EA; Fujinaga Y; Pellett S
    mBio; 2024 Mar; 15(3):e0310623. PubMed ID: 38347673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN).
    Bigalke H; Rummel A
    Toxins (Basel); 2015 Nov; 7(12):4895-905. PubMed ID: 26610569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BoNT/AB hybrid maintains similar duration of paresis as BoNT/A wild-type in murine running wheel assay.
    Kutschenko A; Reinert MC; Krez N; Liebetanz D; Rummel A
    Neurotoxicology; 2017 Mar; 59():1-8. PubMed ID: 28043867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging opportunities for serotypes of botulinum neurotoxins.
    Peng Chen Z; Morris JG; Rodriguez RL; Wagle Shukla A; Tapia-Núñez J; Okun MS
    Toxins (Basel); 2012 Nov; 4(11):1196-222. PubMed ID: 23202312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the rat digit abduction score (DAS) assay: Evaluation of botulinum neurotoxin activity in the gastrocnemius lateralis, peronei, and extensor digitorum longus.
    Cornet S; Périer C; Kalinichev M
    Toxicon X; 2020 Jun; 6():100029. PubMed ID: 32550584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test.
    Weisemann J; Krez N; Fiebig U; Worbs S; Skiba M; Endermann T; Dorner MB; Bergström T; Muñoz A; Zegers I; Müller C; Jenkinson SP; Avondet MA; Delbrassinne L; Denayer S; Zeleny R; Schimmel H; Åstot C; Dorner BG; Rummel A
    Toxins (Basel); 2015 Nov; 7(12):5035-54. PubMed ID: 26703728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S; Bradshaw M; Tepp WH; Pier CL; Whitemarsh RCM; Chen C; Barbieri JT; Johnson EA
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
    Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
    J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
    MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids.
    Smith TJ; Hill KK; Foley BT; Detter JC; Munk AC; Bruce DC; Doggett NA; Smith LA; Marks JD; Xie G; Brettin TS
    PLoS One; 2007 Dec; 2(12):e1271. PubMed ID: 18060065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A.
    Miyashita SI; Karatsu S; Fujiishi M; Huang IH; Nagashima Y; Morobishi T; Hosoya K; Hata T; Dong M; Sagane Y
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo inhibition of Clostridium botulinum neurotoxin types B, C, E, and F by small molecular weight inhibitors.
    Montgomery VA; Ahmed SA; Olson MA; Mizanur RM; Stafford RG; Roxas-Duncan VI; Smith LA
    Toxicon; 2015 May; 98():12-9. PubMed ID: 25707753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and ex vivo screening of candidate therapeutics to restore neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A1.
    Beske PH; Bradford AB; Hoffman KM; Mason SJ; McNutt PM
    Toxicon; 2018 Jun; 147():47-53. PubMed ID: 29054436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.